• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者术前血浆中微生物16S rDNA易位水平升高与前列腺切除术后复发相关。

Increased Preoperative Plasma Level of Microbial 16S rDNA Translocation Is Associated With Relapse After Prostatectomy in Prostate Cancer Patients.

作者信息

Ou Tongwen, Zhou Zejun, Turner David P, Zhu Baoli, Lilly Michael, Jiang Wei

机构信息

Department of Urology, Capital Medical University Affiliated XuanWu Hospital, Beijing, China.

State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Sciences, Hunan Normal University, Changsha, China.

出版信息

Front Oncol. 2020 Jan 15;9:1532. doi: 10.3389/fonc.2019.01532. eCollection 2019.

DOI:10.3389/fonc.2019.01532
PMID:32010622
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6974797/
Abstract

The environmental factors for promoting prostate cancer (PCa) recurrence remain unknown. A retrospective cross-sectional study was conducted in healthy men ( = 12) and PCa patients undergoing prostatectomy ( = 27). Plasma preoperative level of total cell-free bacterial 16S rDNA, a marker of microbial translocation, was evaluated by qPCR. Plasma levels of prostate-specific antigen (PSA) were evaluated by ELISA. Similar degrees of microbial translocation were found in healthy men and patients. However, the levels of microbial 16S rDNA were increased in patients with cancer relapse ( = 10) compared to patients without relapse ( = 17) after prostatectomy. Furthermore, the levels of microbial 16S rDNA were marginally increased in patients with pT3 or pT4 tumors compared to those with pT 2 or less. The levels of microbial 16S rDNA tended to increase in patients with higher pathologic tumor stage, Gleason score, and margin and lymph node involvements; but these differences did not reach significance. The plasma 16S rDNA levels increased in patients with PCa who have biochemical recurrence and 16S rDNA levels were higher in patients with higher-grade PCa.

摘要

促进前列腺癌(PCa)复发的环境因素尚不清楚。对健康男性(n = 12)和接受前列腺切除术的PCa患者(n = 27)进行了一项回顾性横断面研究。通过qPCR评估术前血浆中总游离细菌16S rDNA水平,这是微生物易位的一个标志物。通过ELISA评估前列腺特异性抗原(PSA)的血浆水平。在健康男性和患者中发现了相似程度的微生物易位。然而,与前列腺切除术后未复发的患者(n = 17)相比,癌症复发患者(n = 10)的微生物16S rDNA水平升高。此外,与pT2或更低分期的患者相比,pT3或pT4肿瘤患者的微生物16S rDNA水平略有升高。微生物16S rDNA水平在病理肿瘤分期、Gleason评分、切缘和淋巴结受累程度较高的患者中呈上升趋势;但这些差异未达到显著水平。发生生化复发的PCa患者血浆16S rDNA水平升高,高级别PCa患者的16S rDNA水平更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be39/6974797/56d5be0f3e4b/fonc-09-01532-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be39/6974797/56d5be0f3e4b/fonc-09-01532-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be39/6974797/56d5be0f3e4b/fonc-09-01532-g0001.jpg

相似文献

1
Increased Preoperative Plasma Level of Microbial 16S rDNA Translocation Is Associated With Relapse After Prostatectomy in Prostate Cancer Patients.前列腺癌患者术前血浆中微生物16S rDNA易位水平升高与前列腺切除术后复发相关。
Front Oncol. 2020 Jan 15;9:1532. doi: 10.3389/fonc.2019.01532. eCollection 2019.
2
Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.临床局限性前列腺癌单纯根治性前列腺切除术后临床及病理因素与前列腺特异性抗原水平升高的相关性
Urology. 1996 Aug;48(2):249-60. doi: 10.1016/S0090-4295(96)00167-7.
3
Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.T1-2期前列腺癌:根治性前列腺切除术后影响生化及临床失败因素的多变量分析
Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52. doi: 10.1016/s0360-3016(96)00590-1.
4
The results of radical prostatectomy at a community hospital during the prostate specific antigen era.前列腺特异性抗原时代一家社区医院根治性前列腺切除术的结果
Cancer. 1996 Mar 1;77(5):928-33. doi: 10.1002/(sici)1097-0142(19960301)77:5<928::aid-cncr19>3.0.co;2-5.
5
Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.耻骨后根治性前列腺切除术后早期前列腺特异性抗原复发:基于术前和术后肿瘤特征的预测
Eur Urol. 1999;36(1):21-30. doi: 10.1159/000019922.
6
Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.机器人辅助根治性前列腺切除术后患者前列腺特异性抗原持续升高的预测因素及肿瘤学结局
J Robot Surg. 2017 Mar;11(1):37-45. doi: 10.1007/s11701-016-0606-8. Epub 2016 May 31.
7
Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control.耻骨后根治性前列腺切除术后的前列腺特异性抗原。复发模式与癌症控制
Urol Clin North Am. 1997 May;24(2):395-406. doi: 10.1016/s0094-0143(05)70386-4.
8
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.1992年和2002年病理T3亚分期对根治性前列腺切除术后生化复发预测的比较评估。
Cancer. 2006 Feb 15;106(4):775-82. doi: 10.1002/cncr.21632.
9
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
10
Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.术前转化生长因子β1(TGF-β1)的血浆水平可强烈预测接受根治性前列腺切除术患者的病情进展。
J Clin Oncol. 2001 Jun 1;19(11):2856-64. doi: 10.1200/JCO.2001.19.11.2856.

引用本文的文献

1
Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy.推进前列腺癌治疗:粪便微生物群移植作为辅助治疗的作用。
Curr Res Microb Sci. 2025 Jun 11;9:100420. doi: 10.1016/j.crmicr.2025.100420. eCollection 2025.
2
Influence of diabetes on microbiome in prostate tissues of patients with prostate cancer.糖尿病对前列腺癌患者前列腺组织微生物群的影响。
Front Oncol. 2024 Aug 16;14:1445375. doi: 10.3389/fonc.2024.1445375. eCollection 2024.
3
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?

本文引用的文献

1
A protocol for quantizing total bacterial 16S rDNA in plasma as a marker of microbial translocation in vivo.一种将血浆中总细菌16S rDNA定量作为体内微生物易位标志物的方案。
Cell Mol Immunol. 2018 Oct;15(10):937-939. doi: 10.1038/cmi.2018.3. Epub 2018 Apr 16.
2
Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer.对前列腺癌活检结果为阳性和阴性的男性的尿液微生物群进行分析。
J Urol. 2018 Jan;199(1):161-171. doi: 10.1016/j.juro.2017.08.001. Epub 2017 Aug 7.
3
Inflammation, Microbiota, and Prostate Cancer.
肠道微生物群在前列腺癌中的潜在作用:免疫、代谢产物、作用途径?
Front Oncol. 2023 May 17;13:1196217. doi: 10.3389/fonc.2023.1196217. eCollection 2023.
4
Possibilities and limitations of using low biomass samples for urologic disease and microbiome research.使用低生物量样本进行泌尿系统疾病和微生物组研究的可能性与局限性。
Prostate Int. 2022 Dec;10(4):169-180. doi: 10.1016/j.prnil.2022.10.001. Epub 2022 Oct 7.
5
Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.精准肿瘤学的新方向:癌症-微生物组领域中出现的循环微生物DNA
Precis Clin Med. 2022 Feb 3;5(1):pbac005. doi: 10.1093/pcmedi/pbac005. eCollection 2022 Mar.
6
Prostate Microbiota and Prostate Cancer: A New Trend in Treatment.前列腺微生物群与前列腺癌:一种新的治疗趋势。
Front Oncol. 2021 Dec 10;11:805459. doi: 10.3389/fonc.2021.805459. eCollection 2021.
炎症、微生物群与前列腺癌
Eur Urol Focus. 2016 Oct;2(4):374-382. doi: 10.1016/j.euf.2016.08.010. Epub 2016 Aug 28.
4
Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.人类口腔微生物群与胰腺癌的前瞻性风险:一项基于人群的巢式病例对照研究。
Gut. 2018 Jan;67(1):120-127. doi: 10.1136/gutjnl-2016-312580. Epub 2016 Oct 14.
5
The role of myeloid cells in cancer therapies.髓系细胞在癌症治疗中的作用。
Nat Rev Cancer. 2016 Jul;16(7):447-62. doi: 10.1038/nrc.2016.54.
6
Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses.与高危型人乳头瘤病毒感染妇女中高级别宫颈上皮内瘤变相关的宫颈微生物组。
Cancer Prev Res (Phila). 2016 May;9(5):357-66. doi: 10.1158/1940-6207.CAPR-15-0350. Epub 2016 Mar 2.
7
Racial differences in the relationship between clinical prostatitis, presence of inflammation in benign prostate and subsequent risk of prostate cancer.临床前列腺炎、良性前列腺炎症与后续前列腺癌风险之间关系的种族差异。
Prostate Cancer Prostatic Dis. 2016 Jun;19(2):145-50. doi: 10.1038/pcan.2015.54. Epub 2015 Dec 1.
8
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota.通过CTLA-4阻断进行的抗癌免疫疗法依赖于肠道微生物群。
Science. 2015 Nov 27;350(6264):1079-84. doi: 10.1126/science.aad1329. Epub 2015 Nov 5.
9
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages.肿瘤诱导的髓系细胞偏向:当髓系来源的抑制细胞遇上肿瘤相关巨噬细胞时
J Clin Invest. 2015 Sep;125(9):3365-76. doi: 10.1172/JCI80006. Epub 2015 Sep 1.
10
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers.是否应该设计一种Toll样受体4(TLR-4)激动剂或拮抗剂来治疗癌症?TLR-4:其在十种最常见癌症中的表达及作用。
Onco Targets Ther. 2013 Nov 5;6:1573-87. doi: 10.2147/OTT.S50838.